Use of machine learning to predict medication adherence in individuals at risk for atherosclerotic cardiovascular disease.

Medication adherence machine learning cardiovascular diseases cloud computing Surveys and questionnaires

Journal

Smart health (Amsterdam, Netherlands)
ISSN: 2352-6483
Titre abrégé: Smart Health (Amst)
Pays: Netherlands
ID NLM: 101706213

Informations de publication

Date de publication:
Dec 2022
Historique:
medline: 12 5 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Medication nonadherence is a critical problem with severe implications in individuals at risk for atherosclerotic cardiovascular disease. Many studies have attempted to predict medication adherence in this population, but few, if any, have been effective in prediction, sug-gesting that essential risk factors remain unidentified. This study's objective was to (1) establish an accurate prediction model of medi-cation adherence in individuals at risk for atherosclerotic cardiovascular disease and (2) identify significant contributing factors to the predictive accuracy of medication adherence. In particular, we aimed to use only the baseline questionnaire data to assess medication adherence prediction feasibility. A sample of 40 individuals at risk for atherosclerotic cardiovascular disease was recruited for an eight-week feasibility study. After collecting baseline data, we recorded data from a pillbox that sent events to a cloud-based server. Health measures and medication use events were analyzed using machine learning algorithms to identify variables that best predict medication adherence. Our adherence prediction model, based on only the ten most relevant variables, achieved an average error rate of 12.9%. Medication adherence was closely correlated with being encouraged to play an active role in their treatment, having confidence about what to do in an emergency, knowledge about their medications, and having a special person in their life. Our results showed the significance of clinical and psychosocial factors for predicting medication adherence in people at risk for atherosclerotic cardiovascular diseases. Clini-cians and researchers can use these factors to stratify individuals to make evidence-based decisions to reduce the risks.

Sections du résumé

Background UNASSIGNED
Medication nonadherence is a critical problem with severe implications in individuals at risk for atherosclerotic cardiovascular disease. Many studies have attempted to predict medication adherence in this population, but few, if any, have been effective in prediction, sug-gesting that essential risk factors remain unidentified.
Objective UNASSIGNED
This study's objective was to (1) establish an accurate prediction model of medi-cation adherence in individuals at risk for atherosclerotic cardiovascular disease and (2) identify significant contributing factors to the predictive accuracy of medication adherence. In particular, we aimed to use only the baseline questionnaire data to assess medication adherence prediction feasibility.
Methods UNASSIGNED
A sample of 40 individuals at risk for atherosclerotic cardiovascular disease was recruited for an eight-week feasibility study. After collecting baseline data, we recorded data from a pillbox that sent events to a cloud-based server. Health measures and medication use events were analyzed using machine learning algorithms to identify variables that best predict medication adherence.
Results UNASSIGNED
Our adherence prediction model, based on only the ten most relevant variables, achieved an average error rate of 12.9%. Medication adherence was closely correlated with being encouraged to play an active role in their treatment, having confidence about what to do in an emergency, knowledge about their medications, and having a special person in their life.
Conclusions UNASSIGNED
Our results showed the significance of clinical and psychosocial factors for predicting medication adherence in people at risk for atherosclerotic cardiovascular diseases. Clini-cians and researchers can use these factors to stratify individuals to make evidence-based decisions to reduce the risks.

Identifiants

pubmed: 37169026
doi: 10.1016/j.smhl.2022.100328
pmc: PMC10168531
mid: NIHMS1894127
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIA NIH HHS
ID : R21 AG053162
Pays : United States
Organisme : NINR NIH HHS
ID : R21 NR015410
Pays : United States

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Health Psychol. 2016 May;21(5):750-8
pubmed: 24925547
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Clin Ther. 2019 Jan;41(1):107-117
pubmed: 30591287
J Palliat Care. 1991 Summer;7(2):6-9
pubmed: 1714502
J Affect Disord. 2004 Feb;78(2):131-40
pubmed: 14706723
J Cardiovasc Nurs. 2015 Jan-Feb;30(1):51-7
pubmed: 24365871
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Heart. 2014 Feb;100(4):288-94
pubmed: 24186563
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
BMC Fam Pract. 2009 Aug 23;10:58
pubmed: 19698153
J Appl Stat. 2019;46(16):2987-3007
pubmed: 33012942
Curr Cardiol Rep. 2016 May;18(5):49
pubmed: 27098670
Gen Hosp Psychiatry. 2012 May-Jun;34(3):249-53
pubmed: 22401705
J Am Coll Cardiol. 2016 Aug 23;68(8):789-801
pubmed: 27539170
Am J Med. 2015 Dec;128(12):1351-61
pubmed: 26302142
Aging Clin Exp Res. 2016 Apr;28(2):339-46
pubmed: 26142623
J Manag Care Spec Pharm. 2018 May;24(5):469-477
pubmed: 29694288
Tunis Med. 2019 Apr;97(4):564-571
pubmed: 31729707
Prev Med. 2017 Jun;99:269-276
pubmed: 28315760
Front Neuroinform. 2014 Feb 21;8:14
pubmed: 24600388
Ann Transl Med. 2019 Apr;7(7):152
pubmed: 31157273
Gen Hosp Psychiatry. 2003 Jul-Aug;25(4):277-83
pubmed: 12850660
BMC Health Serv Res. 2020 Dec 4;20(1):1125
pubmed: 33276786
Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):41-51
pubmed: 29275361
Med Care. 2019 Jul;57(7):560-566
pubmed: 31157707
J Gen Intern Med. 2016 Aug;31(8):929-40
pubmed: 27160414
BMC Med Res Methodol. 2017 Dec 6;17(1):162
pubmed: 29207961
J Manag Care Spec Pharm. 2018 Nov;24(11):1146-1155
pubmed: 30362915
JAMA. 2018 Dec 18;320(23):2461-2473
pubmed: 30561486
Nature. 2020 Sep;585(7825):357-362
pubmed: 32939066
BMC Public Health. 2020 Feb 19;20(1):257
pubmed: 32075614
Nurs Res Pract. 2013;2013:563246
pubmed: 23956853
J Gerontol Nurs. 2017 Oct 1;43(10):37-45
pubmed: 28556872
Qual Life Res. 2019 Apr;28(4):1053-1061
pubmed: 30470970
PLoS One. 2018 Sep 4;13(9):e0202986
pubmed: 30180180
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
Eur J Prev Cardiol. 2017 Jun;24(9):962-970
pubmed: 28436725
Ophthalmology. 2020 Jan;127(1):45-51
pubmed: 31561878
Can J Cardiol. 2018 Feb;34(2):117-124
pubmed: 29289400
Qual Life Res. 2019 Aug;28(8):2183-2193
pubmed: 31037591
Int J Chron Obstruct Pulmon Dis. 2019 Jul 10;14:1503-1515
pubmed: 31371936
Eur J Cardiovasc Nurs. 2015 Oct;14(5):395-404
pubmed: 25669661
BMJ Open Diabetes Res Care. 2019 Nov 18;7(1):e000761
pubmed: 31803482
Health Psychol. 2013 Jun;32(6):637-46
pubmed: 22746258
Med Clin (Barc). 2019 Jul 5;153(1):1-5
pubmed: 30503066
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):487-490
pubmed: 29480983
J Clin Psychol. 1991 Nov;47(6):756-61
pubmed: 1757578
Med J Aust. 2014 Jul 7;201(1):35-9
pubmed: 24999896
Health Qual Life Outcomes. 2018 May 2;16(1):80
pubmed: 29716589
Sensors (Basel). 2020 May 06;20(9):
pubmed: 32384737
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
BMJ Open. 2018 Jan 21;8(1):e016982
pubmed: 29358417
BMC Bioinformatics. 2017 Jan 3;18(1):9
pubmed: 28049413
PLoS One. 2019 Jan 17;14(1):e0201196
pubmed: 30653535
J Pharm Pract. 2018 Jun;31(3):322-334
pubmed: 28539102
PLoS One. 2017 Nov 2;12(11):e0187139
pubmed: 29095870
Environ Int. 2019 Sep;130:104934
pubmed: 31229871
Support Care Cancer. 2021 Feb;29(2):595-603
pubmed: 32918128
BMC Med Res Methodol. 2016 Aug 18;16:100
pubmed: 27538955
Acad Emerg Med. 2012 Aug;19(8):959-67
pubmed: 22853804
Support Care Cancer. 2020 Aug;28(8):3921-3926
pubmed: 31858249
Circulation. 2018 May 15;137(20):2128-2138
pubmed: 29386204
JAMA Psychiatry. 2020 May 1;77(5):534-540
pubmed: 31774490
Diabetes Educ. 2016 Feb;42(1):34-71
pubmed: 26637240
Ann Intern Med. 2012 Dec 4;157(11):785-95
pubmed: 22964778
Arch Intern Med. 2003 Dec 8-22;163(22):2775-83
pubmed: 14662633
PLoS One. 2018 Jun 27;13(6):e0198578
pubmed: 29949589
Semin Dial. 2019 Nov;32(6):562-574
pubmed: 31309612
JAMA Netw Open. 2020 Apr 1;3(4):e203032
pubmed: 32301989

Auteurs

Seyed Iman Mirzadeh (SI)

School of Electrical Engineering & Computer Science, Washington State University, Pullman, WA, 99163, USA.

Asiful Arefeen (A)

College of Health Solutions, Arizona State University, Phoenix, AZ, 85004, USA.

Jessica Ardo (J)

Sue & Bill Gross School of Nursing University of California Irvine, Irvine, CA, 92697, USA.

Ramin Fallahzadeh (R)

Department of Biomedical Data Sciences, Stanford University, Stanford, CA, 94305, USA.

Bryan Minor (B)

School of Electrical Engineering & Computer Science, Washington State University, Pullman, WA, 99163, USA.

Jung-Ah Lee (JA)

Sue & Bill Gross School of Nursing University of California Irvine, Irvine, CA, 92697, USA.

Janett A Hildebrand (JA)

Department of Nursing at the School of Social Work, University of Southern California, Los Angeles, CA, 90089, USA.

Diane Cook (D)

School of Electrical Engineering & Computer Science, Washington State University, Pullman, WA, 99163, USA.

Hassan Ghasemzadeh (H)

College of Health Solutions, Arizona State University, Phoenix, AZ, 85004, USA.

Lorraine S Evangelista (LS)

School of Nursing, University of Nevada, Las Vegas, NV, 89154, USA.

Classifications MeSH